4 trends tracked about this subject — the full history, oldest to newest below.
Novo Nordisk has filed a lawsuit against Eli Lilly over allegations of deceptive and misleading advertising regarding GLP-1 weight-loss drugs.
FDA’s new peptide panel sparks regulatory debate as biotech giants Lilly and Novo eye the next health wave.
An AI biotech firm has acquired Novo's Parkinson's stem cell therapy following promising data from a phase 1/2 human clinical trial.
13 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.